Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ACTC > SEC Filings for ACTC > Form 8-K on 12-Aug-2013All Recent SEC Filings

Show all filings for ADVANCED CELL TECHNOLOGY, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ADVANCED CELL TECHNOLOGY, INC.


12-Aug-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On August 12, 2013, Advanced Cell Technology, Inc. (the "Company") issued a press release regarding the election of members to its board of directors, a proposed reverse stock split, a proposed increase in the number of authorized shares of its common stock, and other matters to be acted upon at the Company's annual meeting of shareholders to be held on October 22, 2013. A copy of the Company's press release is attached hereto as Exhibit 99.1.

Additional Information and Where to Find It

The Company will file with the Securities and Exchange Commission (the "SEC") and will furnish to stockholders of record on the record date for the annual meeting a definitive proxy statement in connection with the election of members to its board of directors, reverse stock split, increase in authorized shares of common stock, and other matters to be acted upon at the annual meeting. The Company, its chief executive officer Gary Rabin, and certain of its directors, executive officers and other members of management may, under SEC rules, be deemed "participants" in the solicitation of proxies from the Company's stockholders with respect to the election of members to its board of directors, reverse stock split, increase in authorized shares of common stock, and the other matters to be acted upon at the annual meeting. INVESTORS AND STOCKHOLDERS ARE ADVISED TO READ THE DEFINITIVE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED DIRECTOR NOMINEES, REVERSE STOCK SPLIT AND increase in authorized shares of common stock,AS WELL AS OTHER IMPORTANT INFORMATION INCLUDING THOSE PERSONS WHO MAY BE DEEMED "PARTICIPANTS" IN THE SOLICITATION. Investors and stockholders may obtain a free copy of the definitive proxy statement, and other documents filed by the Company with the SEC (including the preliminary proxy statement), at the SEC's web site at http://www.sec.gov. Free copies of the definitive proxy statement and the Company's other filings with the SEC may also be obtained from the Company by directing a request to Advanced Cell Technology, Inc., 33 Locke Drive, Marlborough, Massachusetts 01752, Attention: Secretary.



Item 9.01 Financial Statements and Exhibits.

Exhibit No. Description
99.1 Press Release dated August 12, 2013.

  Add ACTC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ACTC - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.